3[3]Evans ME,Feola D J,J,Rapp R P,et al.Polymyxin B Sulfate and colistion:old antibiotics for emerging muhiresistant gramnegative bacteria[J].Ann Pharmacother,1999,33(9):960-967.
4[4]Loppnow H,Libby P,Freudenberg M,et al.Cytokine induction by lipopolysaccharide(LPS)corresponds to lethal toxicitv and is inhibited by nontoxic Rhodobacter capsulatus LPS[J].Infect Immun,1990,58(11):3743-3750.
6[6]Jackman J E,Fierke C A,Tumey L N,et al.Antibacterial agents that target lipid A biosynthesis in Gram-negative bactera[J].JBiol Chem,2000,275(15):11002.
7[7]Steven M,Richard L.Antiendotoxin strategies for the prevention and treatment of septic shock[J].Drugs,1998,55(4):497.
8[8]Danner R L,van Dervort A L,Doerfler M E,et al.Antiendotoxin activity of lipid A analogues:requirement of the chemical structure[J].Pharm Res,1990,7(3):260-263.
9[9]Christ W J,Asano O,Robidoux A L,et al.E5531,A pure endotoxin antagonist of hish potency[J].Science,1995,268(5207):80-83.
10[10]Kawata T,Bristol J R,Rossignol D P,et al.E5531,A synthetic non-toxin lipid A derivate blicks the immunbiological activities of liopolysaccharide[J].Br J Pharmacol,1999,127(4):853-862.
